| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.098 | 0.06 |